TP73-AS1 was an oncogenic lncRNA that targeted miR-200a to reduce its inhibiting effect on HMGB1, which promoted NF-κB signaling of HCC and its downstream cytokines levels (84). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.